Nuzenio

Why Tarsus Pharmaceuticals

Why Tarsus Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 16 publisher sources 100/100 entity strength

Latest news

Why Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus - simplywall.stsimplywall.st · Sun, 09 Aug 2026 08:50:32 GMT Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 07 Aug 2026 13:52:54 GMT Tarsus Pharmaceuticals Reports Loss for Q2 2026, Misses Estimates - AlphaStreetAlphaStreet · Thu, 06 Aug 2026 19:42:28 GMT Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 19:14:51 GMT Tarsus Pharmaceuticals Inc (TARS) (Q2 2026) Earnings Call Highlights: Record XDEMVY Sales and ... - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 19:02:11 GMT Tarsus Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TARS) 2026-08-06 - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 18:32:18 GMT Tarsus Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreetAlphaStreet · Thu, 06 Aug 2026 18:24:58 GMT Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals - eyewire.newseyewire.news · Thu, 06 Aug 2026 15:47:52 GMT

Timeline

Sun, 09 Aug 2026 08:50:32 GMTWhy Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus - simplywall.st

Fri, 07 Aug 2026 13:52:54 GMTTarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million - Pharmaceutical Executive

Thu, 06 Aug 2026 19:42:28 GMTTarsus Pharmaceuticals Reports Loss for Q2 2026, Misses Estimates - AlphaStreet

Thu, 06 Aug 2026 19:14:51 GMTAlkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma Dive

Thu, 06 Aug 2026 19:02:11 GMTTarsus Pharmaceuticals Inc (TARS) (Q2 2026) Earnings Call Highlights: Record XDEMVY Sales and ... - Yahoo Finance

Thu, 06 Aug 2026 18:32:18 GMTTarsus Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TARS) 2026-08-06 - Seeking Alpha

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Tarsus Pharmaceuticals16 live mentions TARS14 live mentions Inc8 live mentions Alkeus7 live mentions Acquire Alkeus Pharmaceuticals6 live mentions Tarsus6 live mentions Pharmaceuticals4 live mentions Loss3 live mentions StockInvest3 live mentions Is Up2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Why Tarsus Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

16 distinct publisher/source names are currently connected to this entity page.